Design review in South Australia: origins and influence: Stuart Harrison in conversation with Kirsteen Mackay and Paul Finch

ABSTRACTThis paper is the first of two linked papers that focus on the work of the Royal Fine Art Commission (RFAC), which, for three quarters of a century, held the mantel of the UK Government’s advisor on design in the built environment for England and Wales. The paper draws on archival and documentary evidence to explore the important work and concerns of the RFAC from its creation in 1924 and its early years, through to the post-war construction boom and into the 1980s and a new less paternalistic era of government. Analysis of the archives is supplemented by what the limited available literature tells us about the RFAC. As the instigator of a national design review service covering England and Wales, the work of the RFAC forms an important context for understanding more recent approaches to design review, both in the UK and internationally, that today form a critical component of contemporary planning practices.

The fields of architecture and planning face growing pressure to address increasingly complex and interconnected challenges, ranging from reducing carbon emissions and building climate resilience to the meaningful recognition of Country and improving housing affordability. Over the past 15 years design review programs adopted across nearly every state and territory in Australia have responded to these and other issues, leading to a variety of modes and experiences of design review. This article presents a discussion led by Tim Horton (Commissioner, Land and Environment Court of NSW), conducted online during the Government Architects Network of Australia (GANA) meeting on December 3rd, 2024. The discussants comprise Australia’s government architects at the time of meeting: Jill Garner (Victoria), Emma Williamson (Western Australia), Abbie Galvin (New South Wales), Catherine Townsend (Australian Capital Territory), Leah Lang (Queensland), and Kirsteen Mackay (South Australia). GANA meets bi-monthly to discuss design review, as well as other local, state and national issues and opportunities, drawing on the diversity of knowledge, skills, experience and resources of the group and its broader teams. In this discussion, the group explores the state of Australian design review and its response to contemporary challenges: examining how each state tailors its approach to local needs and contexts, how design review interacts with planning systems, and what opportunities lie in the future.

Alors que les autorites decident d'augmenter les taxes sur le carburant Diesel et tentent de promouvoir des carburants moins polluants, il nous a semble utile de travailler sur la formation des suies durant la combustion dans les moteurs, afin d'en limiter l'emission. Le chapitre 1 de ce memoire reprend des generalites sur la combustion, sur les mecanismes d'oxydation, sur la formation des suies et presente une revue bibliographique des travaux anterieurs sur le cyclohexene et le propadiene. Le chapitre Il presente les montages experimentaux utilises pour ce travail, en detaillant le montage de flamme laminaire de premelange installee durant cette these. Le chapitre III presente les mecanismes reactionnels ecrits afin de reproduire nos resultats experimentaux. Les chapitres IV et V presentent les resultats experimentaux obtenus en flamme pour le propadiene et en tube a onde de choc et en reacteur parfaitement agite pour le cyclohexene ainsi que leurs comparaisons avec les simulations. .

Proceedings of the Australian Society for Medical Research.

Peter Graeme Petty – Neurosurgeon (4 July 1934–4 January 2010)

Emerald Studies in Sport and Gender promotes research on two important and related areas within sport studies: women and gender. The concept of gender is included in the series title in order to problematise traditional binary thinking that classifies individuals as male or female, rather than looking at the full gender spectrum. In sport contexts, this is a particularly relevant and controversial issue, for example, in the case of transgendered athletes and female athletes with hyperandrogenism. The concept of sport is interpreted broadly to include activities ranging from physical recreation to high-performance sport. The interdisciplinary nature of the series will encompass social and cultural history and philosophy as well as sociological analyses of contemporary issues. Since any analysis of sport and gender has political implications and advocacy applications, learning from history is essential. Contributors to the series are encouraged to develop an intersectional analysis where appropriate, by examining how multiple identities, including gender, sexuality, ethnicity, social class and ability, intersect to shape the sport experiences of women and men who are Indigenous, racialised, members of ethnic minorities, LGBTQ, working class or disabled. We welcome submissions from both early career and more established researchers.

This study compares the views of primary teachers from South Australia and New South Wales on selected aspects of inclusive education. The questionnaire administered in the study probed the following issues: (i) the numbers and types of students with special needs in inclusive classes; (ii) any benefits that had occurred as a result of including children with disabilities in mainstream classes; (iii) the types of disability or , ‘special educational need’ most difficult to cater for in the regular classroom; (iv) the teachers’ level of satisfaction with the personal and material support available within their schools; and (v) the amount of special education training each teacher received during their pre‐service and in‐service experience. The questionnaire was sent to a representative sample of schools listed in the Disadvantaged Schools and Country Areas Programs in both states. Seventy‐seven (77) responses were received and analysed, comprising forty‐one (41) from teachers in South Australia and thirty‐six (36) from teachers in New South Wales. The overall patterns of responses from teachers in NSW and South Australia were similar. Major findings indicate that approximately one third of teachers in both South Australia and New South Wales report definite benefits associated with having students with disabilities enrolled in their classrooms. However, teachers in both states also report that the major difficulties they encounter are ‘lack of time’, combined with difficulty balancing the demands of all students. Specific obstacles to implementing inclusive practice included class size, lack of appropriate teaching resources, behaviour problems exhibited by some students (resulting in a need for constant behaviour management), and lack of appropriate professional training in inclusive methods. The article discusses these and other factors reported by the teachers. This investigation adds usefully to Australian research into problems and practices associated with inclusion. Peter Westwood is an Associate Professor in the Department of Education, University of Hong Kong, where he teaches and researches in the field of special education. For twenty‐five years he was a teacher, lecturer and researcher in Australia. He is author of the recent books Commonsense methods for children with special needs (published by Routledge), Spelling: approaches to teaching and assessment, and Numeracy and learning difficulties (both published by Australian Council for Educational Research). Lorraine Graham is senior lecturer in Special Education at the University of New England. After some years as a primary teacher in Queensland, she completed her Masters and Ph.D. at Simon Fraser University in Vancouver, British Columbia. Lorraine is particularly interested in ways to foster the literacy skills of students with learning difficulties. Her current projects focus on cognitive strategy instruction, inclusive education and automatkity in basic academic skills.

Economic Papers: A journal of applied economics and policyVolume 19, Issue 1 p. 65-79 THE PRIVATISATION OF EMPLOYMENT SERVICES: HAS IT WORKED FOR THE MOST DISADVANTAGED? KATRINA ALFORD, KATRINA ALFORD Dr Katrina Alford is a Senior Lecturer in the Department of Rural Health in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. Nancy Gullo is a practising accountant since having completed a Bachelor of Business-Accounting degree at La Trobe University.Search for more papers by this authorNANCY GULLO, NANCY GULLO Dr Katrina Alford is a Senior Lecturer in the Department of Rural Health in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. Nancy Gullo is a practising accountant since having completed a Bachelor of Business-Accounting degree at La Trobe University.Search for more papers by this author KATRINA ALFORD, KATRINA ALFORD Dr Katrina Alford is a Senior Lecturer in the Department of Rural Health in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. Nancy Gullo is a practising accountant since having completed a Bachelor of Business-Accounting degree at La Trobe University.Search for more papers by this authorNANCY GULLO, NANCY GULLO Dr Katrina Alford is a Senior Lecturer in the Department of Rural Health in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. Nancy Gullo is a practising accountant since having completed a Bachelor of Business-Accounting degree at La Trobe University.Search for more papers by this author First published: 13 April 2010 https://doi.org/10.1111/j.1759-3441.2000.tb00953.xCitations: 4 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume19, Issue1March 2000Pages 65-79 RelatedInformation

Fiscal StudiesVolume 9, Issue 2 p. 57-71 The New Pension Scheme in Britain JOHN CREEDY, JOHN CREEDY John Creedy is the Truby Williams Professor of Economics at the University of Melbourne, Australia. Richard Disney is Senior Lecturer in Economics at the University of Kent at Canterbury.Search for more papers by this authorRICHARD DISNEY, RICHARD DISNEY John Creedy is the Truby Williams Professor of Economics at the University of Melbourne, Australia. Richard Disney is Senior Lecturer in Economics at the University of Kent at Canterbury.Search for more papers by this author JOHN CREEDY, JOHN CREEDY John Creedy is the Truby Williams Professor of Economics at the University of Melbourne, Australia. Richard Disney is Senior Lecturer in Economics at the University of Kent at Canterbury.Search for more papers by this authorRICHARD DISNEY, RICHARD DISNEY John Creedy is the Truby Williams Professor of Economics at the University of Melbourne, Australia. Richard Disney is Senior Lecturer in Economics at the University of Kent at Canterbury.Search for more papers by this author First published: May 1988 https://doi.org/10.1111/j.1475-5890.1988.tb00320.xCitations: 16 The authors would like to thank Andrew Dilnot and Ian Walker for useful comments on an earlier draft. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume9, Issue2May 1988Pages 57-71 RelatedInformation

Foreword

ABSTRACTThis paper is the second of two linked papers that focus on the work of the Royal Fine Art Commission (RFAC), which for three quarters of a century held the mantel of the UK Government’s advisor on design in the built environment. This paper tells the story of the organization’s final 15 years when, under a new and charismatic leader, the Commission substantially changed its modus operandi, and came out of the shadows, although without ever fully embracing the modern era of government. Analysis of the archives are supplemented by what the limited available literature tells us about the RFAC and by a small number of interviews with key stakeholders with first-hand experience of the operation of the RFAC; those who either worked for it, were responsible for it within Government, or were reviewed by it. The experience offers valuable insights into the practices and problematics of design governance that today, internationally, forms one of the keystones of modern day planning.

Editorial introductions

Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Bernard ThongBernard ThongDr Thong graduated from the National University of Singapore in 1994. He subsequently went on to complete his senior residency in Rheumatology and Clinical Immunology/Allergy at Tan Tock Seng Hospital, Singapore from 1999–2002. This was followed by a clinical fellowship in paediatric and adult Clinical Immunology/Allergy at the University of Southampton and Southampton General Hospital, United Kingdom from 2002–2003. He is Head and Senior Consultant at the Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, and is author or co-author of over 40 peer-reviewed publications. He is a member of the Rheumatology Specialists Training Committee, and Vice-President of the Allergy and Clinical Immunology Society (Singapore). He is also international fellow and member of the American Academy of Allergy, Asthma and Immunology's Adverse Reactions to Drugs, Biologicals and Latex Committee; World Allergy Organization's web regional editor for the Asia Pacific, co-chair of the Drug Allergy Special Committee and member of the Anaphylaxis Special Committees. He is also a member of the editorial board for the journal Allergy. Miguel BlancaMiguel BlancaDr Miguel Blanca graduated from the Faculty of Medicine, University of Granada, Spain, in 1975. He undertook specialist training in allergy from 1976 to 1979 at Carlos Haya Hospital, Malaga, Spain, in the Department of Internal Medicine. Between 1980 and 1982 he undertook further training in allergy and immunology at the Middlesex Hospital, London, UK in the department of Professor Ivan Roit. He was a staff member of the Allergy Unit at Carlos Haya Hospital from 1983 to 1999, and from 1997 to 1999 he was director of the research unit of Carlos Haya Hospital. Between 2000 and 2003 he was chief of the Allergy Service at La Paz Hospital, Madrid, Spain. In 2004 he was appointed as Head of the Allergy Service at Carlos Haya Hospital. He has he research group in the BIONAN instituto, Technology Park, Malaga, Spain, a center dedicated to nanomedicine and since 2011 he has been nominated Associate Professor at the University of Nancy, France. Since 2008 he has also been the Director of the Spanish National Network for Adverse Reactions to Drugs and Allergens. This consists of a consortium made up of 10 hospitals and five research institutes belonging to different universities and to the Spanish Research Council (CSIC). Dr Blanca has published more than 200 original manuscripts in peer review journals and has received more than 40 grants during his carrier from National and European institutions as well as the pharmaceutical industry. He is a member of the American Academy for Allergy and Immunology, the European Academy of Allergy, the Colegium Allergologicum Internationale and several Spanish national societies and research institutes. Major topics of the research are allergic drug reactions, food allergy as well as the local immune response of tissues and organs to allergens and drugs. Theodore FreemanTheodore FreemanDr Freeman graduated from the University of South Florida College of Medicine, USA and did his postgraduate training in Internal Medicine (IM) at Jacksonville, Florida, USA and Keesler Air Force Base Medical Center, Biloxi Mississippi, USA. He completed his adult and pediatric allergy and immunology (AI) training at Wilford Hall Medical Center, Texas, USA. He did a year of clinical lab immunology (CLI) at Massachusetts General Hospital in Boston USA. He was the Training Program Director of allergy/immunology fellowship at Wilford Hall from 1989 to 2004. He retired from the United States Air Force in 2001 with the rank of Colonel. Dr Freeman is board certified in IM, AI and CLI. He is a fellow of the American College of Physicians, American Academy of Asthma Allergy and Immunology and the American College of Asthma Allergy and Immunology. He has served on the Residency Review Committee for Allergy/Immunology (part of the Accreditation Council for Graduate Medical Education) and the Advisory Council for the National Institute of Allergy and Infectious Diseases (part of NIH). He has also served on the Board of Governors of the Texas Allergy, Asthma and Immunology Society, and on the Board of Governors of the San Antonio Region of the American Lung Association. He has served as President of both the Society of Air Force Physicians and the Association of Uniformed Services Allergists and Immunologists. He is currently the President elect of the Texas Allergy Asthma and Immunology Society, and on the Board of Directors for the American Academy of Allergy Asthma and Immunology. He is currently in the private practice of allergy and immunology in San Antonio, Texas. Ralf Günter HeineRalf Günter HeineDr Ralf G. Heine graduated from the Medical School at the University of Göttingen, Germany. After completing his residency in Pediatrics at the Children's Hospital in Bremen, Germany, he completed his training in Pediatrics at the Royal Children's Hospital, Melbourne, Australia. He then enrolled in a three-year fellowship program in Pediatric Gastroenterology and Nutrition at the same hospital. Dr Heine completed a Doctor of Medicine, by thesis, on the topic of ‘Gastroesophageal reflux disease in chronic childhood illness’ at the University of Melbourne. In 1998, he took up his appointment as Pediatric Gastroenterologist in the Department of Gastroenterology & Clinical Nutrition at the Royal Children's Hospital, Melbourne. In 2000, Dr Heine also commenced clinical work as a gastroenterologist in the Department of Allergy & Immunology, and has since held joint appointments as Senior Staff Specialist in both departments. Dr Heine has been appointed as a Senior Lecturer in the Department of Pediatrics at the University of Melbourne, and he is a Senior Research Fellow at the Murdoch Children's Research Institute in Melbourne, Australia. Dr Heine is a member of the Research Advisory Committee of the Royal Australasian College of Physicians, the Australasian Society of Allergy & Immunology, the American Gastroenterological Association and the Special Committee on Food Allergy of the World Allergy Organization. His clinical work and research interests have focused on aspects of cow's milk and egg allergy, anaphylaxis, gastrointestinal food allergy, food intolerances, non-IgE-mediated food allergy, infantile colic, celiac disease and eosinophilic gastrointestinal disorders. Dr Heine has published over 60 peer-reviewed articles, six book chapters and has given many invited presentations at national and international scientific meetings. David A. KhanDavid A. KhanDr. David A. Khan is Professor of Medicine and Pediatrics at the University of Texas Southwestern Medical Center in Dallas, USA. He is the Program Director for the Allergy & Immunology fellowship program at Southwestern. Dr. Khan is a Past-President of the Texas Allergy, Asthma and Immunology Society. He is also a member of the Joint Task Force on Practice Parameters for Allergy & Immunology. Dr. Khan received his medical degree from the University of Illinois in Chicago, USA. After completing an Internal Medicine residency at the Good Samaritan Medical Center in Phoenix, Arizona, USA, he went on to fellowship training in Allergy & Immunology at the Mayo Clinic, USA. His research interests include rush immunotherapy, drug allergy, mood disorders in asthma and alternative therapies for refractory chronic urticaria. Enrico CompalatiEnrico CompalatiDr Compalati MD, PhD, graduated from Medical School at the University of Genoa, Italy. After his residency in Internal Medicine, he received his degree in Allergy and Clinical Immunology. His post-graduate experiences include a PhD-doctorate in Clinical-Experimental Allergy & Respiratory Physiopathology and a Master course in Immunotherapy of Allergic and Respiratory Diseases at the same University. Currently he is researcher and clinician allergist at the Allergy and Respiratory Diseases Clinic of the Genoa University, with particular interests in allergen specific immunotherapy, allergic inflammation, drug therapy of respiratory allergy and impact of allergic conditions on health-related quality of life. His scientific activity is mainly focused on the evidence-based methodology applied to allergy and respiratory diseases. In this field he is co-author of several systematic reviews and was visiting fellow at the department of Clinical Epidemiology & Biostatistics of the McMaster University, ON, Canada. Since 2008 onwards, he has been member of the committee of the World Allergy Organization (WAO) for the Evidence Based Medicine and Methodology and served as author for the Allergy Prevalence Survey by the World Allergy Organization 2007, the WAO Sublingual Immunotherapy Position Paper 2009, the WAO Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines 2010. He is connected in the GA2LEN (the EU Network of Excellence in Allergy) and collaborates with the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) Working Group. He is member of the interest group for immunotherapy of the European Academy of Allergy and Clinical Immunology (EAACI), International-member of the American Academy of Allergy Asthma and Immunology (AAAAI) and member of the Panel for Italian Guidelines on Allergic Rhinitis and its Impact on Asthma (ARIA). Associate faculty member of F1000 for Asthma & Allergic Rhinitis, he is author of different publications in peer-reviewed journals and served as Lecturer and Chair at national and international congresses.

Medical Journal of AustraliaVolume 1, Issue 3 p. 88-89 Point of View DOCTOR WHY ARE YOU SO DETACHED? Anthony R. Moore M.S., F.R.A.C.S., B.A. (Cantab.), Corresponding Author Anthony R. Moore M.S., F.R.A.C.S., B.A. (Cantab.) Senior Lecturer n/a@dne.dne Department of Surgery, The University of MelbourneAddress for reprints: Anthony R. Moore, Senior Lecturer, Department of Surgery, University of Melbourne, Royal Melbourne Hospital, Vic. 3050.Search for more papers by this author Anthony R. Moore M.S., F.R.A.C.S., B.A. (Cantab.), Corresponding Author Anthony R. Moore M.S., F.R.A.C.S., B.A. (Cantab.) Senior Lecturer n/a@dne.dne Department of Surgery, The University of MelbourneAddress for reprints: Anthony R. Moore, Senior Lecturer, Department of Surgery, University of Melbourne, Royal Melbourne Hospital, Vic. 3050.Search for more papers by this author First published: 01 February 1979 https://doi.org/10.5694/j.1326-5377.1979.tb112011.xCitations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume1, Issue3February 1979Pages 88-89 RelatedInformation

Health technology assessment (HTA) is a multidisciplinary process that determines the value of health technology at different points in its lifecycle. Safety issues have become more important since regulatory authorities are increasingly adopting flexible standards, processes, and evidentiary requirements for drug approval. In this article, we compared the different role of regulatory authorities and HTA agencies. Additionally, the experience of regulatory-HTA collaboration for assessment and/or decision-making on safety issues in the lifecycle of a health technology is illustrated, including olmesartan (angiotensin II receptor antagonist) and the direct-acting hepatitis C virus (HCV) antiviral agents. Post-licensing data can be derived from various sources such as electronic health records, medical claims, drug and disease registries, post-authorization safety studies (PASS) or post-authorization safety efficacy studies (PAES), periodic benefit-risk assessment reports, as well as HTA reassessment reports, which incorporate utilization information from patients in a real-world setting and provide crucial evidence for various purposes. With the ongoing accumulation of safety and efficacy information during post-regulatory approval, a standardized process for continuous data collection and active reassessment of risk and benefit becomes crucial for managing the lifecycle of health technologies. In order to define evidence requirements clearly, reduce uncertainty, and minimize delays in HTA approval, early engagement and collaboration of HTA agencies in the regulatory review processes have become more common. However, there is currently limited interaction and collaboration between regulatory authorities and HTA agencies. This article aims to identify the challenges faced by regulators and HTA agencies today, emphasizing the significance of conducting regulatory reviews and health technology assessments throughout a technology's lifecycle, underlining the value of utilizing real-world data and evidence, and emphasizing the necessity of enhancing collaboration between regulatory authorities and HTA agencies, all within the overarching context of drug safety.